Impact of vessel volume on thermodilution measurements in patients with coronary microvascular dysfunction.

absolute coronary flow bolus thermodilution coronary microvascular dysfunction microvascular resistance vessel lumen volume

Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
02 Apr 2024
Historique:
revised: 05 02 2024
received: 14 11 2023
accepted: 19 03 2024
medline: 3 4 2024
pubmed: 3 4 2024
entrez: 3 4 2024
Statut: aheadofprint

Résumé

Two invasive methods are available to estimate microvascular resistance: bolus and continuous thermodilution. Comparative studies have revealed a lack of concordance between measurements of microvascular resistance obtained through these techniques. This study aimed to examine the influence of vessel volume on bolus thermodilution measurements. We prospectively included patients with angina with non-obstructive coronary arteries (ANOCA) undergoing bolus and continuous thermodilution assessments. All patients underwent coronary CT angiography to extract vessel volume. Coronary microvascular dysfunction was defined as coronary flow reserve (CFR) < 2.0. Measurements of absolute microvascular resistance (in Woods units) and index of microvascular resistance (IMR) were compared before and after volumetric adjustment. Overall, 94 patients with ANOCA were included in this study. The mean age was 64.7 ± 10.8 years, 48% were female, and 19% had diabetes. The prevalence of CMD was 16% based on bolus thermodilution, while continuous thermodilution yielded a prevalence of 27% (Cohen's Kappa 0.44, 95% CI 0.23-0.65). There was no correlation in microvascular resistance between techniques (r = 0.17, 95% CI -0.04 to 0.36, p = 0.104). The adjustment of IMR by vessel volume significantly increased the agreement with absolute microvascular resistance derived from continuous thermodilution (r = 0.48, 95% CI 0.31-0.63, p < 0.001). In patients with ANOCA, invasive methods based on coronary thermodilution yielded conflicting results for the assessment of CMD. Adjusting IMR with vessel volume improved the agreement with continuous thermodilution for the assessment of microvascular resistance. These findings strongly suggest the importance of considering vessel volume when interpreting bolus thermodilution assessment.

Sections du résumé

BACKGROUND BACKGROUND
Two invasive methods are available to estimate microvascular resistance: bolus and continuous thermodilution. Comparative studies have revealed a lack of concordance between measurements of microvascular resistance obtained through these techniques.
AIMS OBJECTIVE
This study aimed to examine the influence of vessel volume on bolus thermodilution measurements.
METHODS METHODS
We prospectively included patients with angina with non-obstructive coronary arteries (ANOCA) undergoing bolus and continuous thermodilution assessments. All patients underwent coronary CT angiography to extract vessel volume. Coronary microvascular dysfunction was defined as coronary flow reserve (CFR) < 2.0. Measurements of absolute microvascular resistance (in Woods units) and index of microvascular resistance (IMR) were compared before and after volumetric adjustment.
RESULTS RESULTS
Overall, 94 patients with ANOCA were included in this study. The mean age was 64.7 ± 10.8 years, 48% were female, and 19% had diabetes. The prevalence of CMD was 16% based on bolus thermodilution, while continuous thermodilution yielded a prevalence of 27% (Cohen's Kappa 0.44, 95% CI 0.23-0.65). There was no correlation in microvascular resistance between techniques (r = 0.17, 95% CI -0.04 to 0.36, p = 0.104). The adjustment of IMR by vessel volume significantly increased the agreement with absolute microvascular resistance derived from continuous thermodilution (r = 0.48, 95% CI 0.31-0.63, p < 0.001).
CONCLUSIONS CONCLUSIONS
In patients with ANOCA, invasive methods based on coronary thermodilution yielded conflicting results for the assessment of CMD. Adjusting IMR with vessel volume improved the agreement with continuous thermodilution for the assessment of microvascular resistance. These findings strongly suggest the importance of considering vessel volume when interpreting bolus thermodilution assessment.

Identifiants

pubmed: 38566527
doi: 10.1002/ccd.31020
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 Wiley Periodicals LLC.

Références

Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med 2010;362:886‐895.
Mileva N, Nagumo S, Mizukami T, et al. Prevalence of coronary microvascular disease and coronary vasospasm in patients with nonobstructive coronary artery disease: systematic review and meta‐analysis. J Am Heart Assoc 2022;11:e023207.
Kelshiker MA, Seligman H, Howard JP, et al. Coronary flow reserve and cardiovascular outcomes: a systematic review and meta‐analysis. Eur Heart J 2022;43:1582‐1593.
van 't Veer M, Adjedj J, Wijnbergen I, et al. Novel monorail infusion catheter for volumetric coronary blood flow measurement in humans: in vitro validation. EuroIntervention. 2016;12:701‐707.
Everaars H, de Waard GA, Schumacher SP, et al. Continuous thermodilution to assess absolute flow and microvascular resistance: validation in humans using [15O]H2O positron emission tomography. Eur Heart J 2019;40:2350‐2359.
Gallinoro E, Bertolone DT, Fernandez‐Peregrina E, et al. Reproducibility of bolus versus continuous thermodilution for assessment of coronary microvascular function in patients with ANOCA. EuroIntervention. 2023;19:e155‐e166.
Fearon WF, Balsam LB, Farouque H.M.O., et al. Novel index for invasively assessing the coronary microcirculation. Circulation 2003;107:3129‐3132.
Fairbairn TA, Dobson R, Hurwitz‐Koweek L, et al. Sex differences in coronary computed tomography angiography‐derived fractional flow reserve. JACC: Cardiovasc Imaging. 2020;13:2576‐2587.
Grover R, Leipsic JA, Mooney J, et al. Coronary lumen volume to myocardial mass ratio in primary microvascular angina. J Cardiovasc Comput Tomogr. 2017;11:423‐428.
De Bruyne B, Pijls NHJ, Gallinoro E, et al. Microvascular resistance reserve for assessment of coronary Microvascular Function. J Am Coll Cardiol 2021;78:1541‐1549.
Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020;41:407‐477.
Hittner JB, May K, Silver NC. A Monte Carlo evaluation of tests for comparing dependent correlations. J Gen Psychol 2003;130:149‐168
Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 2008;88:1009‐1086.
De Bruyne B, Pijls N.H.J., Smith L, Wievegg M, Heyndrickx GR. Coronary thermodilution to assess flow reserve: experimental validation. Circulation 2001;104:2003‐2006.
Doucette JW, Corl PD, Payne HM, et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992;85:1899‐1911.
Gould KL, Johnson NP, Narula J. Microvascular dysfunction or diffuse epicardial cad with normal stress vasodilation. JACC: Cardiovasc Imaging. 2023;16:549‐552.
Fearon WF, Low AF, Yong AS, et al. Prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention. Circulation 2013;127:2436‐2441.
Nishi T, Murai T, Ciccarelli G, et al. Prognostic value of coronary microvascular function measured immediately after percutaneous coronary intervention in stable coronary artery disease: an international multicenter study. Circ: Cardiovasc Interv. 2019;12:e007889.
Lee JM, Jung JH, Hwang D, et al. Coronary flow reserve and microcirculatory resistance in patients with intermediate coronary stenosis. J Am Coll Cardiol 2016;67:1158‐1169.
Maznyczka AM, Oldroyd KG, Greenwood JP, et al. Comparative significance of invasive measures of microvascular injury in acute myocardial infarction. Circ: Cardiovasc Interv. 2020;13:e008505.
Echavarría‐Pinto M, van de Hoef TP, Nijjer S, et al. Influence of the amount of myocardium subtended to a coronary stenosis on the index of microcirculatory resistance. Implications for the invasive assessment of microcirculatory function in ischaemic heart disease. EuroIntervention. 2017;13:944‐952.

Auteurs

Koshiro Sakai (K)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.
Department of Medicine, Division of Cardiology, Showa University School of Medicine, Tokyo, Japan.

Tatyana Storozhenko (T)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.
Department of Prevention and Treatment of Emergency Conditions, L.T. Malaya Therapy National Institute NAMSU, Kharkiv, Ukraine.

Takuya Mizukami (T)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.
Division of Clinical Pharmacology, Department of Pharmacology, Showa University, Tokyo, Japan.
Department of Cardiovascular Medicine, Gifu Heart Center, Gifu, Japan.

Hirofumi Ohashi (H)

Department of Cardiology, Aichi Medical University, Aichi, Japan.

Frederic Bouisset (F)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.
Department of Cardiology, Toulouse University Hospital, Toulouse, France.

Atomu Tajima (A)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.
Department of Cardiology, Aichi Medical University, Aichi, Japan.

Lieven van Hoe (L)

Department of Radiology, OLV Clinic, Aalst, Belgium.

Emanuele Gallinoro (E)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Giulia Botti (G)

Interventional Cardiology Unit, IRCCS Ospedale San Raffaele, Milan, Italy.

Thabo Mahendiran (T)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.

Sofie Pardaens (S)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.

Sofie Brouwers (S)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.
Department of Experimental Pharmacology, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.

Samer Fawaz (S)

Essex Cardiothoracic Centre, Mid and South Essex NHS Foundation Trust, Basildon, UK.
MTRC, Anglia Ruskin School of Medicine, Chelmsford, Essex, UK.

Thomas R Keeble (TR)

Essex Cardiothoracic Centre, Mid and South Essex NHS Foundation Trust, Basildon, UK.
MTRC, Anglia Ruskin School of Medicine, Chelmsford, Essex, UK.

John R Davies (JR)

Essex Cardiothoracic Centre, Mid and South Essex NHS Foundation Trust, Basildon, UK.
MTRC, Anglia Ruskin School of Medicine, Chelmsford, Essex, UK.

Jeroen Sonck (J)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.

Bernard De Bruyne (B)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.
Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland.

Carlos Collet (C)

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium.

Classifications MeSH